An international team of researchers bioengineering human liver tissues uncovered previously unknown networks of genetic-molecular crosstalk that control the organ's developmental processes – greatly ...

A study reveals advances in the understanding and treatment of liver fibrosis, a serious complication in the context of metabolic fatty liver disease, also known as MASLD (metabolic ...

Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in financing to advance its research and development. CEO Dr. John Swart announced ...

Pfizer announced on Monday that it is halting development of its oral weight-loss pill after one patient experienced liver issues. The company said it halted development of danuglipron, an oral drug ...

Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In A Nutshell Liver cells under chronic dietary stress essentially “forget” their ...

The liver is accountable for metabolizing most medications and is therefore one of the primary tissues affected by adverse drug reactions. Most classes of medicine can cause drug-induced liver injury ...

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration is shown in Silver Spring near Washington Dec 8 (Reuters) - The U.S. Food and Drug Administration has qualified the first ...

Pedestrians walk by the Pfizer corporate headquarters in New York City (2020). On Monday the company said it was discontinuing development of a weight-loss drug in pill form. File Photo by John ...

VivoSim Labs' NAMkind™ platform shows 87.5% predictive accuracy for liver toxicity, enhancing drug safety and reducing development costs. VivoSim Labs, Inc. announced the successful performance of its ...